Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/04/2012 | EP1487805B1 Pyrimidine derivatives |
07/04/2012 | EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts |
07/04/2012 | EP1461047B1 Compositions and methods for animal treatment |
07/04/2012 | EP1439858B1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
07/04/2012 | EP1349580B2 Process to improve stability of a pharmaceutical composition |
07/04/2012 | EP1051174B2 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
07/04/2012 | CN202288921U Compound naproxen esomeprazole tablet |
07/04/2012 | CN202287453U Traditional Chinese Medicinal pillow for treating cervical spondylosis |
07/04/2012 | CN1993313B Antibiotic compound |
07/04/2012 | CN1964965B Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
07/04/2012 | CN1964736B Dalbavancin compositions for treatment of bacterial infections |
07/04/2012 | CN1962641B Metalloproteinase inhibitors |
07/04/2012 | CN1953965B Novel cis-imidazolines |
07/04/2012 | CN1907967B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
07/04/2012 | CN1907293B Combined medicine for treating lpneumonia and preparing process thereof |
07/04/2012 | CN1901901B Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
07/04/2012 | CN1893827B Silver dihydrogen citrate compositions comprising a second antimicrobial agent |
07/04/2012 | CN1882687B Method of growing myocardial cells |
07/04/2012 | CN1882354B 细胞因子调节剂及相关用法 Cytokines regulate agents and related usage |
07/04/2012 | CN1874777B 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
07/04/2012 | CN1857497B Erosion treating Chinese medicine ointment and its quality control method |
07/04/2012 | CN1845911B Condensed ring compound and use thereof |
07/04/2012 | CN1832928B 5-membered heterocycle-based p38 kinase inhibitors |
07/04/2012 | CN1809557B Compound |
07/04/2012 | CN1791592B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions |
07/04/2012 | CN1713897B Sustained release preparation |
07/04/2012 | CN1668613B Flavone derivatives of inhibitors of cyclin-dependent kinases |
07/04/2012 | CN1536986B Intravaginal drug delivery devices for administration of antimicrobial agent |
07/04/2012 | CN1503796B Polymorphic and other crystalling forms of cis-ftc |
07/04/2012 | CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
07/04/2012 | CN1338939B Compositions for the treatment of male erectile dysfunction |
07/04/2012 | CN102549158A Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3 |
07/04/2012 | CN102549153A Prophylactic and/or therapeutic agent for metabolic syndrome |
07/04/2012 | CN102549152A Adenoviral-based vectors |
07/04/2012 | CN102549007A Method for making 3alpha-hydroxy, 3beta- methyl-5alpha-pregnan-20-one (ganaxolone) |
07/04/2012 | CN102549005A Method for the preparation of a crystalline form of 1-chloro-4- (beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene |
07/04/2012 | CN102549000A Fused thiazolo and oxazolo pyrimidinones |
07/04/2012 | CN102548995A Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
07/04/2012 | CN102548993A Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
07/04/2012 | CN102548992A 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors |
07/04/2012 | CN102548991A Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10A inhibitors |
07/04/2012 | CN102548990A Inhibitors of phosphatidylinositol 3-kinase |
07/04/2012 | CN102548989A Sphingosine-1-phosphate receptor agonists |
07/04/2012 | CN102548987A Fluoro-substituted compounds as kinase inhibitors and methods of use thereof |
07/04/2012 | CN102548986A Aminopyrrolidinone derivatives and uses thereof |
07/04/2012 | CN102548985A Substituted carbonyl compounds |
07/04/2012 | CN102548984A Inhibitors of PI3 kinase and / or MTOR |
07/04/2012 | CN102548983A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor |
07/04/2012 | CN102548982A Azetidinyl diamides as monoacylglycerol lipase inhibitors |
07/04/2012 | CN102548977A Sulfone derivative |
07/04/2012 | CN102548976A (Thio) morpholine derivatives as S1P modulators |
07/04/2012 | CN102548975A Histone deacetylase inhibitors |
07/04/2012 | CN102548974A Novel FXR (NR1H4 ) binding and activity modulating compounds |
07/04/2012 | CN102548971A Crystalline form i rosuvastatin zinc salt |
07/04/2012 | CN102548970A Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as AKT (PKB) phosphorylation inhibitors |
07/04/2012 | CN102548965A 取代酰胺化合物 Substituted amide compounds |
07/04/2012 | CN102548964A Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
07/04/2012 | CN102548963A Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions |
07/04/2012 | CN102548945A Apogossypolone derivatives as anticancer agents |
07/04/2012 | CN102548629A Improved purification of multi-specific receptors |
07/04/2012 | CN102548579A Dosage regimen of an s1p receptor modulator |
07/04/2012 | CN102548572A Vaccines and compositions against streptococcus pneumoniae |
07/04/2012 | CN102548567A Composition comprising curcuma longa extract together with curcuma zedoaria extract |
07/04/2012 | CN102548562A Ophthalmic composition |
07/04/2012 | CN102548561A Ethyleneoxide butyleneoxide block copolymer compositions |
07/04/2012 | CN102548560A Compositions and methods for prevention and treatment of coronary heart diseases |
07/04/2012 | CN102548559A Composition for the treatment of cystic fibrosis |
07/04/2012 | CN102548558A Novel aminopyridine derivatives having Aurora A selective inhibitory action |
07/04/2012 | CN102548557A Compounds for the reduction of beta-amyloid production |
07/04/2012 | CN102548556A Tablet |
07/04/2012 | CN102548555A Compositions and methods for treating parkinson's disease |
07/04/2012 | CN102548554A Method for treating Th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor |
07/04/2012 | CN102548553A Method and composition for treating diabetic ketoacidosis |
07/04/2012 | CN102548552A Spectinamides as anti-tuberculosis agents |
07/04/2012 | CN102548551A Derivatives of N-hydroxybenzamide for treating HIV infections |
07/04/2012 | CN102548550A Exo-S-mecamylamine method, use, and compound for treatment |
07/04/2012 | CN102548549A Methods for treatment of a sarcoma using an epimetabolic shifter (Coenzyme Q10) |
07/04/2012 | CN102548548A Pharmaceutical composition for use in medical and veterinary ophthalmology |
07/04/2012 | CN102548547A Soluble pharmaceutical forms of N,N'-diaminodiphenyl sulphone for optimum use in the treatment of various diseases |
07/04/2012 | CN102548546A Transdermal therapeutic system for administering fentanyl or an analogue thereof |
07/04/2012 | CN102548543A Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
07/04/2012 | CN102548542A Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles |
07/04/2012 | CN102548540A Solid pharmaceutical preparations comprising amphiphilic copolymers on the basis of polyethers in combination with surfactants |
07/04/2012 | CN102548539A Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
07/04/2012 | CN102548538A Topical formulation for diabetic foot ulcers |
07/04/2012 | CN102548537A Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
07/04/2012 | CN102548536A Olopatadine compositions and uses thereof |
07/04/2012 | CN102548535A Sublingual and buccal film compositions |
07/04/2012 | CN102548530A 黑色素产生抑制剂 Melanin production inhibitor |
07/04/2012 | CN102548529A Collagen production accelerating composition |
07/04/2012 | CN102548417A Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor |
07/04/2012 | CN102548407A The use of metabotropic glutamate receptor potentiators for reducing nicotine dependence |
07/04/2012 | CN102548406A Process for the synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5'7'-tetraiodo-3h-spiro[isobenzofuran-1,9'-xanthen]-3-one (rose bengal) and related xanthenes |
07/04/2012 | CN102539466A Method for screening medicament for treating brain injury |
07/04/2012 | CN102533996A Method for determining APRIL (A Proliferation-inducing Ligand) gene promoter and transcription factor binding site and use |
07/04/2012 | CN102533600A Marine streptomyces/pyranosesquiterpene compound and preparation method and application thereof |
07/04/2012 | CN102533588A Lactobacillus brevis for producing extracellular exopolysaccharide and application thereof |
07/04/2012 | CN102532341A Extraction method and application of chroogomphus rutilus polysaccharide |
07/04/2012 | CN102532339A Method for selenizing pilose asiabell root polysaccharides and application of product |
07/04/2012 | CN102532263A Bi-component drug micromolecule hydrogel based on hexadecadrol and taxol and preparation method thereof |